(Q38079750)

28 August 2017

title

Role of leukotriene antagonists and antihistamines in the treatment of allergic rhinitis (English)

1 reference

28 August 2017

1 reference

4

Cemal Cingi

1 reference

28 August 2017

Bengü Cobanoğlu

1

1 reference

28 August 2017

Elina Toskala

series ordinal

2

1 reference

28 August 2017

Ahmet Ural

series ordinal

3

1 reference

28 August 2017

publication date

1 April 2013

1 reference

Current Allergy and Asthma Reports

28 August 2017

published in

1 reference

28 August 2017

volume

13

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

203-208

1 reference

Effects of loratadine/montelukast on vigilance and alertness task performance in a simulated cabin environment

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Update on the medical treatment of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Histamine and leukotriene receptor antagonism in the treatment of allergic rhinitis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Montelukast in the management of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Allergic rhinitis and its pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Early and late nasal symptom response to allergen challenge. The effect of pretreatment with a glucocorticosteroid spray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

The pathophysiology, diagnosis and treatment of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Allergic rhinitis: an update on disease, present treatments and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Pharmacology and safety of the leukotriene antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Molecular mechanisms of allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Histamine-mediated mechanisms in the human nasal airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Antiallergic effects of H1-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Immunohistochemical localization of histamine receptor subtypes in human inferior turbinates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Histamine in the immune regulation of allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Novos anti-histamínicos: uma visão crítica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Topical azelastine in perennial allergic conjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Leukotriene C: a slow-reacting substance from murine mastocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

The role of leukotrienes in nasal allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

The role of leukotrienes in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Montelukast in the treatment of allergic rhinitis: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Montelukast in allergic rhinitis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Cost and resource utilization comparisons of second-generation antihistamines vs. montelukast for allergic rhinitis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Recent advances in antileukotriene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0341-4

Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009.

21 January 2018

1 reference

12 December 2020

EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists

1 reference

12 December 2020

Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.

1 reference

12 December 2020

New antihistamines: a critical view

1 reference

12 December 2020

Allergen uptake and presentation by dendritic cells

1 reference

12 December 2020

Leukotriene modifiers in the management of asthma.

1 reference

12 December 2020

Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy

1 reference

12 December 2020

Efficacy of montelukast and loratadine as treatment for allergic rhinitis in children

1 reference

12 December 2020

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial

1 reference

12 December 2020

10.1007/S11882-013-0341-4

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1043164509

0 references

1 reference